| Code | CSB-RA011669MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to GSK-3888130B, targeting interleukin-7 (IL-7), a critical cytokine in the immune system. IL-7 plays an essential role in T cell and B cell development, homeostasis, and survival by binding to the IL-7 receptor (IL-7R) and activating downstream signaling pathways including JAK-STAT and PI3K-AKT. This cytokine is particularly important for maintaining peripheral T cell populations and supporting lymphocyte proliferation. Dysregulated IL-7 signaling has been implicated in various autoimmune conditions, inflammatory diseases, and certain lymphoid malignancies, making it a relevant therapeutic target for immune-mediated disorders.
GSK-3888130B is an anti-IL-7 monoclonal antibody designed to mimic or enhance the signaling of IL-7, promoting the proliferation, survival and function of T cells, thereby strengthening the immune system. This biosimilar antibody provides researchers with a valuable tool for investigating IL-7-mediated immune responses, studying T cell biology, and exploring the role of this cytokine in autoimmune pathogenesis and lymphocyte homeostasis. It enables mechanistic studies of IL-7 signaling pathways and supports preclinical research into immune system regulation and potential therapeutic interventions.
There are currently no reviews for this product.